Nrf2 Biosensor Stop Codon Translation Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antioxidant therapies fail to effectively address oxidative stress due to limitations in distributing exogenous antioxidants throughout the body to meet oxidative demand, and redox balance is primarily maintained by endogenous enzyme systems rather than direct exogenous compounds.
Innovation Solution
Development of a biosensor comprising an isolated nucleic acid or cDNA encoding a C-terminal fragment of Nuclear factor-erythroid 2 related factor 2 (Nrf2) linked to a detectable moiety, with a stop codon between the fragment and the moiety, to identify agents that modulate Nrf2 translation, thereby inducing antioxidant defenses.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If exogenous antioxidant compounds are administered to meet oxidative stress demand, then antioxidant capacity is improved, but distribution quantity throughout the body is insufficient
Solution Approach 1:
The invention activates the body's own endogenous antioxidant enzyme systems through Nrf2 pathway modulation, allowing cells to produce their own antioxidants rather than relying on external administration. This self-service mechanism enables sufficient antioxidant capacity without the distribution limitations of exogenous compounds
Solution Approach 2:
The biosensor comprising Nrf2 fragment fused to a detectable moiety serves as an intermediary tool to identify and screen compounds that can activate endogenous antioxidant pathways. This mediator enables the selection of agents that trigger internal antioxidant production, resolving the contradiction between achieving antioxidant capacity and distribution limitations
2Reliability
If biosensor is designed with stop codon between Nrf2 fragment and detectable moiety, then translation modulation capability is improved, but biosensor structure complexity increases
Solution Approach 1:
The biosensor is segmented into distinct functional modules: an Nrf2 fragment containing the translation modulation domain, a stop codon element, and a detectable moiety. This segmentation allows the stop codon to be precisely positioned to control translation without requiring complex overall structure, as each segment performs a specific function independently
Solution Approach 2:
The stop codon is placed at a specific local position within the biosensor sequence to confer translation modulation capability. This localized feature provides the necessary functional control without requiring complexity throughout the entire biosensor structure, achieving reliable translation modulation with minimal overall complexity
Data Source
AI summary
Compositions include nucleic acid sequences encoding the C-terminal fragment of fragment (Seg3) of Nuclear factor-erythroid 2 related factor 2 (Nrf2). These compositions provide a target for identification of novel therapeutics having the ability to modulate the translation of Nrf2. Methods of treating subjects are also provided.